BANGKOK (Reuters) – Thailand’s Food and Drug Administration (FDA) has given emergency use authorisation for Sinovac Biotech’s coronavirus vaccine, a senior official told Reuters on Monday.
“The FDA has approved or registered Sinovac’s COVID-19 vaccine for conditional emergency use, effective Feb. 22,” FDA deputy secretary-general Surachok Tangwiwat said, adding it was valid for one year
(Reporting by Panarat Thepgumpanat; Writing by Patpicha Tanakasempipat; Editing by Martin Petty)
